Acute lymphoblastic leukemia.

Acute lymphoblastic leukemia , a form of leukemia, or cancer of the white blood cells characterized by excess lymphoblasts. Acute refers to the relatively short time course of the disease . This disease is caused when multiplying malicious, immature white blood cells continuously and in the bone marrow in the bone marrow. ALL causes damage and death due to crowding normal cells in the bone marrow and spreading to other organs. Although ALL is the most common in childhood with a peak incidence at 2-5 years, this type of leukemia is more common in people over the age of 60.

' ' Theranostic ' treatment for acute lymphoblastic leukemiaA team of researchers at Case Western Reserve University School of Medicine theranostic agents for the treatment of acute lymphoblastic leukemia . ALL is the common form of childhood cancer diagnosed in about 5,000 new cases per year in the United States. Give an insight into give an insight into pediatric oncology, which is specific to the development of theranostic agents. Treatment a selective a selective diagnostic test with targeted therapy on the basis of test results.Gleevec an immediate options to postoperative protective from return of this highly aggressive type disease. .. The Committee shall for Human Medicinal Products recommended approval of Glivec have based positive results from a Phase III study which the use of Glivec after operation shown the risk of relapse reduce recommend by some 89 percent[1]. Of the European Commission generally follows of the for the CHMP recommendations and delivers his final decision within two or three months.